We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Rapid Lateral-Flow Assay Identifies Legionella

By HospiMedica staff writers
Posted on 09 Oct 2006
A new rapid lateral-flow assay enables the simultaneous identification of all Legionella species. More...
The most prominent species, Legionella pneumophila, can be identified separately using the same assay.

The new test, called Duopath Legionella, is available from Merck KGaA (Darmstadt, Germany). It can be used for confirmation of suspect colonies obtained after enrichment of water or environmental samples on buffered charcoal yeast extract (BCYE) agar medium or BCYE with Legionella-selective supplements. The test is highly sensitive and lowers the risk of false-negative results. In a comparative study with the widely used latex-agglutination assay, the sensitivity of Duopath Legionella was shown to be 100% for Legionella pneumophila and 92% for Legionella species, while the latex assay provided only 98% and 37%, respectively.

All warm water samples that are not heated above 56°C are potential sources of Legionella. Thus, water systems in institutions such as hospitals, nursing homes, and schools are frequently analyzed for the presence of Legionella. Some countries require water testing for the presence of Legionella pneumophila, but many countries require analysis for all Legionella species. Duopath Legionella can be used by microbiology laboratories that analyze water samples from various sources (e.g., drinking water from water pipes, warmed pool or shower water, water from cooling towers, and air conditioners).

The assay extends Merck's Singlepath/Duopath lateral-flow program for the rapid and convenient detection and confirmation of Salmonella, Listeria spp., Escherichia coli O157, verotoxin-producing E coli, and Campylobacter. Duopath Legionella is perfectly adapted to Merck's range of culture media for the enrichment of Legionellae.



Related Links:
Merck

Gold Member
Neonatal Heel Incision Device
Tenderfoot
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Rapid Sepsis Test
SeptiCyte RAPID
Gold Member
Blood Gas Analyzer
i-Check200
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: Adobe Stock

New ECG Foundation Model Enables Broad Cardiac Diagnosis and Risk Prediction

Electrocardiograms are central to cardiovascular decision-making, but conventional artificial intelligence models are often trained for narrow tasks, such as detecting a single arrhythmia.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.